GSN and neoplasm: This study identifies a novel integrin binding competition between pGSN and TNC, and GSN gene methylation during ESCC tumor progression causes decreased secretion of pGSN, leading to integrin αvβ3 dysregulation, oncogenic TNC activation, and CAF formation.